Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement
This trial is active, not recruiting.
|Condition||hip replacement arthroplasty|
|Sponsor||Ludwig-Maximilians - University of Munich|
|Start date||August 2011|
|End date||October 2016|
|Trial size||30 participants|
|Trial identifier||NCT01394744, 10-1739 / IIS2009029|
The goal of the study is the analysis of metal ion serum concentrations and of the cytokine production in the blood of patients with a conventional cementless total hip replacement. The rationale is that a) the bearing wear releases particles respectively metal ions into the joint and the blood which will differ in quantity and composition; b) the cytokine production of peripheral blood mononuclear cells (PBMC) might be influenced to a varying degree by the metal and the ceramic particles.
The patients from whom the respective samples will be analyzed are randomized in one of the following three groups: metal-on-metal, ceramic-on-ceramic or ceramic-on-metal. A 36mm bearing is used in all patients. In this separate study, follow-up data of the clinical and radiographic examinations of the patients are available.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
Male or female participants from 18 years up to 75 years old.
- age over 18 years, necessity of hip replacement, informed consent
- acute inflammatory disease, renal disease, other cobalt-chromium implant, ager over 75 years
|Official title||Determination of Metal Ion Levels in the Serum and Assessment of the Respective Cytokine Production of Peripheral Blood Cells in Patients With a Hard-on-hard Bearing Total Hip Replacement|
|Principal investigator||Peter Thomas, Prof.|
Call for more information